48 documents found, page 1 of 5

Sort by Issue Date

Overweight, Obesity, And Cardiovascular Disease In Heterozygous Familial Hyperc...

Elshorbagy, Amany; Vallejo-Vaz, Antonio J.; Barkas, Fotios; Lyons, Alexander R.M.; Stevens, Christophe A.T.; Dharmayat, Kanika I.; Catapano, Alberico L.

Background and aims: Overweight and obesity are modifiable risk factors for atherosclerotic cardiovascular disease (ASCVD) in the general population, but their prevalence in individuals with heterozygous familial hypercholesterolaemia (HeFH) and whether they confer additional risk of ASCVD independent of LDL cholesterol (LDL-C) remains unclear. Methods: Cross-sectional analysis was conducted in 35 540 patients ...


Global variation in lipoprotein/a levels among patients with coronary heart dis...

Barkas, Fotios; Brandts, Julia; De Bacquer, Dirk; Jennings, Catriona; De Backer, Guy G.; Kotseva, Kornelia; Ryden, Lars; Lip, Gregory Y. H.

Background Lipoprotein(a) [Lp(a)] is a common risk factor for atherosclerotic cardiovascular disease, potentially more atherogenic per particle than low-density lipoprotein. An estimated 1.5 billion individuals globally have elevated levels ≥125 nmol/L, considered as a risk-enhancing threshold. Although Lp(a) levels vary by ethnicity, ongoing trials of novel therapies in predominantly secondary prevention patie...


Frequency of residual combined dyslipidemia and hypertriglyceridemia in patient...

Santos, Raul D.; Ray, Kausik K.; De Bacquer, Dirk; Jennings, Catriona; Kotseva, Kornelia; Rydén, Lars; Lip, Gregory Y. H.; Erlund, Iris; Ganly, Sandra

Background and aims: Hypertriglyceridemia (HTG) is independently associated with risk of atherosclerotic events, even when LDL-cholesterol levels appear controlled. This INTERASPIRE study determined the frequency of HTG and residual combined dyslipidemia and their related factors in patients with coronary heart disease (CHD) from 13 countries across six World Health Organization (WHO) regions. Methods: Particip...



Prospective associations between multiple lifestyle behaviors and depressive sy...

Werneck, André O.; Vancampfort, Davy; Stubbs, Brendon; Silva, Danilo R.; Cucato, Gabriel G.; Christofaro, Diego G.D. [UNESP]; Santos, Raul D.

Made available in DSpace on 2022-04-28T19:49:39Z (GMT). No. of bitstreams: 0 Previous issue date: 2022-03-15; Background: Our aim was to analyze the associations between multiple lifestyle behaviors and depressive symptoms. Methods: We included 4,725 adults (18–59y), that provided data in routine health evaluations of a hospital in Brazil, followed for a mean period of 3.1 ± 1.6 years. Physical activity, alcoho...

Date: 2022   |   Origin: Oasisbr

Worldwide experience of homozygous familial hypercholesterolaemia: retrospectiv...

Tromp, Tycho R.; Hartgers, Merel L.; Hovingh, G Kees; Vallejo-Vaz, Antonio J.; Ray, Kausik K.; Soran, Handrean; Freiberger, Tomas; Bertolini, Stefano

Background: Homozygous familial hypercholesterolaemia (HoFH) is a rare inherited disorder resulting in extremely elevated low-density lipoprotein cholesterol levels and premature atherosclerotic cardiovascular disease (ASCVD). Current guidance about its management and prognosis stems from small studies, mostly from high-income countries. The objective of this study was to assess the clinical and genetic charact...


The time is now: Achieving FH paediatric screening across Europe – The Prague D...

Bedlington, Nicole; Abifadel, Marianne; Beger, Birgit; Bourbon, Mafalda; Bueno, Héctor; Ceska, Richard; Cillíková, Kristýna; Cimická, Zdenka

Familial Hypercholesterolaemia (FH) is severely under-recognized, under-diagnosed and under-treated in Europe, leading to a significantly higher risk of premature cardiovascular diseases in those affected. FH stands for inherited, very high cholesterol and affects 1:300 individuals regardless of their age, race, sex, and lifestyle, making it the most common inherited metabolic disorder and a non-modifiable card...


Paediatric familial hypercholesterolaemia screening in Europe: public policy ba...

Gidding, Samuel S.; Wiegman, Albert; Groselj, Urh; Freiberger, Tomas; Peretti, Noel; Dharmayat, Kanika I.; Daccord, Magdalena; Bedlington, Nicola

Familial hypercholesterolaemia (FH) is under-recognized and under-treated in Europe leading to significantly higher risk for premature heart disease in those affected. As treatment beginning early in life is highly effective in preventing heart disease and cost-effective in these patients, screening for FH is crucial. It has therefore now been recognized by the European Commission Public Health Best Practice Po...


COVID-19 and Thromboinflammation: Is There a Role for Statins?

Ferrari, Filipe; Martins, Vítor M.; Teixeira, Marcelo; Santos, Raul D.; Stein, Ricardo

The novel coronavirus disease (COVID-19) showed increased morbidity and mortality rates and worse prognosis in individuals with underlying chronic diseases, especially cardiovascular disease and its risk factors, such as hypertension, diabetes, and obesity. There is also evidence of possible links among COVID-19, myocardial infarction, and stroke. Emerging evidence suggests a pro-inflammatory milieu and hyperco...

Date: 2021   |   Origin: Oasisbr

Association of Omnivorous and Vegetarian Diets With Antioxidant Defense Mechani...

Cinegaglia, Naiara [UNESP]; Acosta-Navarro, Julio; Rainho, Claudia [UNESP]; Antoniazzi, Luiza; Mattioli, Sarah [UNESP]; Pimentel, Caroline

Made available in DSpace on 2020-12-12T01:27:42Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-06-16; Background Evidence that a vegetarian diet rich in antioxidants contributes to cardiovascular health are growing, however, the underlying molecular mechanisms remain unknown. HO-1 (heme-oxygenase-1), a marker of adaptive response, is protective against oxidative stress and has shown cardioprotective eff...

Date: 2020   |   Origin: Oasisbr

48 Results

Queried text

Refine Results

Author





















Date














Document Type




Access rights



Resource




Subject